Table 3. SMN gene copy numbers observed in 25 core families.
Case no. | Clinical type | SMN1/SMN2 ratio | |||
---|---|---|---|---|---|
Patient | Father | Mother | Sib | ||
1 | I | 0:2(M) | 1:1 | 1:1 or1:2a | |
2 | I | 0:2(F) | 1:1 | 1:2 | |
3 | I | 0:2(M) | 1:2 | 1:1 | |
4 | I | 0:2(F) | 1:3 | 2:0a | |
5 | I | 0:3(M) | 2:1b | 1:3 | |
6 | I | 0:2(M) | 1:2 | 1:1 or1:2a | |
7 | I | 0:2(F) | 1:1 | 1:2 | |
8 | I | 0:3(M) | 1:2 | 1:3 | |
9 | I | 1D:3(M) | 1+1D:2 | 1:3 | 2:2(F) |
10 | I | 0:2(M) | 1:1 | 1:2 | |
11 | I | 0:2(M) | 1:2 | 1:1 | |
12 | I | 0:2(M) | 1:2 | 1:3 | |
13 | I | 0:2(F) | 1:2 | 1:3 | |
14 | II | 0:3(M) | 1:2 | 1:3 | |
15 | II | 0:3(M) | 1:3 | 1:1 | |
16 | II | 0:3(F) | 2:1b | 1:3 | |
17 | II | 0:3(M) | 1:1 | 1:2 or 1:3a | |
18 | II | 0:3(F) | 1:2 | 1:3 | |
19 | III | 0:4(F) | 1:2 | 1:3 | 0:2(F) |
20 | III | 0:3(M) | 1:2 | 1:3 | |
21 | III | 0:3(F) | 1:3 | 1:2 or 1:3a | |
22 | III | 0:3(F) | 1:1 | 1:3 | |
23 | III | 0:4(M) | 1:3 | 1:2 or 1:3a | |
24 | III | 0:4(F) | 1:3 | 1:3 | |
25 | III | 1D:3(F) | 1+1D:1 | 1:3 |
M, male; F, female.
Blood samples were not available from these individuals, and therefore their SMN genotypes were assumed based on the genotypes determined for their patients and fathers from the family study.
These two fathers were found to be the ‘carriers with the ‘2+0' genotype by the further family testing.